SYNDAX PHARMACEUTICALS INC (SNDX)
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Mulvihill Canadian Bank Enhanced Yield ETF Declares Monthly Distribution
MercadoLibre, Inc. Reports Second Quarter 2026 Financial Results
Biodesix Announces Second Quarter 2026 Results and Highlights
Vanda Pharmaceuticals Reports Second Quarter 2026 Financial Results
Mirum Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
LegalZoom Reports Second Quarter 2026 Financial Results
Forward Air Corporation Reports Second Quarter 2026 Results
Sunrun Reports Second Quarter 2026 Financial Results
Power Integrations Reports Second-Quarter Financial Results